CDX-MDM

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCDX-MDM
Drug Alias Nameleukotriene A4 hydrolase modulator (Covenant Therapeutics)CDX-MDM4-MDM
ClassificationSmall molecules
Mechanisms of ActionLeukotriene A-4 hydrolase modulatorsAminopeptidase stimulants
TargetsAminopeptidaseLeukotriene A-4 hydrolase
Therapy Area/IndicationsEmphysema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCovenant Therapeutics LlcGeorgetown UniversityUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsEmphysema

Other Information

ATC CodeN/A
Related LinksN/A